Julia Mantaj

653 total citations
19 papers, 498 citations indexed

About

Julia Mantaj is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Julia Mantaj has authored 19 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Julia Mantaj's work include Cancer therapeutics and mechanisms (8 papers), Synthesis and pharmacology of benzodiazepine derivatives (8 papers) and RNA Interference and Gene Delivery (3 papers). Julia Mantaj is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Synthesis and pharmacology of benzodiazepine derivatives (8 papers) and RNA Interference and Gene Delivery (3 papers). Julia Mantaj collaborates with scholars based in United Kingdom, Spain and Italy. Julia Mantaj's co-authors include Driton Vllasaliu, Khondaker Miraz Rahman, Paul J. Jackson, David E. Thurston, Enrico Ferrari, Bahijja Tolulope Raimi‐Abraham, Richard B. Parsons, S. M. Abdur Rahman, Choudhury Mahmood Hasan and Armond Daci and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Cancer Research.

In The Last Decade

Julia Mantaj

18 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Mantaj United Kingdom 11 245 135 114 78 76 19 498
Gopal Pathuri United States 12 198 0.8× 91 0.7× 62 0.5× 72 0.9× 74 1.0× 44 487
Mateusz Psurski Poland 15 220 0.9× 107 0.8× 169 1.5× 82 1.1× 44 0.6× 50 579
Lorelei Irina Braşoveanu Romania 14 145 0.6× 87 0.6× 73 0.6× 54 0.7× 28 0.4× 31 463
Yanfang Wang China 17 174 0.7× 176 1.3× 23 0.2× 39 0.5× 50 0.7× 31 577
Soo-Jeong Lim South Korea 11 283 1.2× 89 0.7× 41 0.4× 37 0.5× 35 0.5× 14 542
Eunjin Lee South Korea 11 173 0.7× 171 1.3× 43 0.4× 23 0.3× 149 2.0× 25 603
Liyun Ji China 13 319 1.3× 103 0.8× 96 0.8× 17 0.2× 82 1.1× 22 537
Florence Gattacceca France 15 326 1.3× 106 0.8× 74 0.6× 23 0.3× 67 0.9× 33 809
Canfeza Sezgin Türkiye 14 325 1.3× 210 1.6× 25 0.2× 18 0.2× 108 1.4× 45 695
Kavita Pal India 14 116 0.5× 70 0.5× 89 0.8× 24 0.3× 29 0.4× 34 429

Countries citing papers authored by Julia Mantaj

Since Specialization
Citations

This map shows the geographic impact of Julia Mantaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Mantaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Mantaj more than expected).

Fields of papers citing papers by Julia Mantaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Mantaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Mantaj. The network helps show where Julia Mantaj may publish in the future.

Co-authorship network of co-authors of Julia Mantaj

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Mantaj. A scholar is included among the top collaborators of Julia Mantaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Mantaj. Julia Mantaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mantaj, Julia, Paul J. Jackson, Richard B. Parsons, et al.. (2025). Transcription Factor Inhibition as a Potential Additional Mechanism of Action of Pyrrolobenzodiazepine (PBD) Dimers. Research Portal (King's College London). 5(1). 8–8.
2.
Mehta, Kosha J., et al.. (2024). University students’ preferences of learning modes post COVID-19-associated lockdowns: In-person, online, and blended. PLoS ONE. 19(7). e0296670–e0296670. 4 indexed citations
3.
Luo, Xiang, Armond Daci, Julia Mantaj, et al.. (2023). Probing milk extracellular vesicles for intestinal delivery of RNA therapies. Journal of Nanobiotechnology. 21(1). 406–406. 19 indexed citations
4.
Mantaj, Julia, et al.. (2020). Cow Milk and Intestinal Epithelial Cell-Derived Extracellular Vesicles as Systems for Enhancing Oral Drug Delivery. Pharmaceutics. 12(3). 226–226. 108 indexed citations
5.
Mantaj, Julia, et al.. (2019). Nanoparticle modification in biological media: implications for oral nanomedicines. RSC Advances. 9(69). 40487–40497. 10 indexed citations
6.
Mantaj, Julia, et al.. (2019). Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics. 11(3). 127–127. 37 indexed citations
7.
Mantaj, Julia, et al.. (2019). Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway. Pharmaceutics. 11(7). 298–298. 37 indexed citations
8.
Mantaj, Julia, et al.. (2018). Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of Macromolecules. Pharmaceutics. 10(4). 188–188. 21 indexed citations
9.
Mantaj, Julia, et al.. (2018). Role of the Basement Membrane as an Intestinal Barrier to Absorption of Macromolecules and Nanoparticles. Molecular Pharmaceutics. 15(12). 5802–5808. 15 indexed citations
10.
Mantaj, Julia, Keith R. Fox, Khondaker Miraz Rahman, et al.. (2018). Abstract 736: Pyridinobenzodiazepines (PDDs): A new class of sequence-selective DNA mono-alkylating ADC payloads with low hydrophobicity. Cancer Research. 78(13_Supplement). 736–736. 4 indexed citations
11.
Mantaj, Julia, Paul J. Jackson, Kersti Karu, Khondaker Miraz Rahman, & David E. Thurston. (2016). Covalent Bonding of Pyrrolobenzodiazepines (PBDs) to Terminal Guanine Residues within Duplex and Hairpin DNA Fragments. PLoS ONE. 11(4). e0152303–e0152303. 10 indexed citations
12.
Mantaj, Julia, Paul J. Jackson, Khondaker Miraz Rahman, & David E. Thurston. (2016). Entwicklung Pyrrolobenzodiazepin(PBD)‐haltiger Antikörper‐Wirkstoff‐Konjugate (ADCs) ausgehend von Anthramycin. Angewandte Chemie. 129(2). 474–502. 12 indexed citations
13.
Jackson, Paul J., et al.. (2016). Abstract 4779: In silico design, synthesis and evaluation of a new family of C1-substituted pyrrolobenzodiazepines (PBDs). Cancer Research. 76(14_Supplement). 4779–4779. 2 indexed citations
14.
Mantaj, Julia, Paul J. Jackson, Khondaker Miraz Rahman, & David E. Thurston. (2016). From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs). Angewandte Chemie International Edition. 56(2). 462–488. 186 indexed citations
15.
Mantaj, Julia, David E. Thurston, & Khondaker Miraz Rahman. (2015). Abstract 1986: Effect of the PBD dimer SJG-136 on expression of STAT3 dependent genes. Cancer Research. 75(15_Supplement). 1986–1986. 1 indexed citations
16.
Mantaj, Julia, S. M. Abdur Rahman, Choudhury Mahmood Hasan, et al.. (2015). Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells. Organic & Biomolecular Chemistry. 13(13). 3882–3886. 27 indexed citations
17.
Mantaj, Julia, Piper Jackson, David E. Thurston, & Khondaker Miraz Rahman. (2014). 42 Interaction of SJG-136 with cognate sequences of oncogenic transcription factors. European Journal of Cancer. 50. 19–19. 1 indexed citations
18.
Mantaj, Julia, et al.. (2014). Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. 1 indexed citations
19.
Mantaj, Julia, David E. Thurston, & Khondaker Miraz Rahman. (2013). Abstract 2230: Interaction of SJG-136 with cognate sequences of oncogenic transcription factors.. Cancer Research. 73(8_Supplement). 2230–2230. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026